Unveiling Allosteric Regulation and Binding Mechanism of BRD9 through Molecular Dynamics Simulations and Markov Modeling
Molecules · 2024
DOI: 10.3390/molecules29153496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Bin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Artificial Intelligence, Shandong University of Traditional Chinese Medicine, Qingdao 266112, China. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Markov Chains, Transcription Factors, Protein Binding. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Demonstration Projects of Science and Technology for the People of Qingdao City, National Nature Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Bromodomain-containing protein 9 (BRD9) is a key player in chromatin remodeling and gene expression regulation, and it is closely associated with the development of various diseases, including cancers. Recent studies have indicated that inhibition of BRD9 may have potential value in the treatment of certain cancers. Molecular dynamics (MD) simulations, Markov modeling and principal component analysis were performed to investigate the binding mechanisms of allosteric inhibitor POJ and orthosteric inhibitor 82I to BRD9 and its allosteric regulation. Our results indicate that binding of these two types of inhibitors induces significant structural changes in the protein, particularly in the formation and dissolution of α-helical regions. Markov flux analysis reveals notable changes occurring in the α-helicity near the ZA loop during the inhibitor binding process. Calculations of binding free energies reveal that the cooperation of orthosteric and allosteric inhibitors affects binding ability of inhibitors to BRD9 and modifies the active sites of orthosteric and allosteric positions. This research is expected to provide new insights into the inhibitory mechanism of 82I and POJ on BRD9 and offers a theoretical foundation for development of cancer treatment strategies targeting BRD9.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Medical Artificial Intelligence, Shandong University of Traditional Chinese Medicine, Qingdao 266112, China.
- School of Science, Shandong Jiaotong University, Jinan 250357, China.
ORCID-Profile: Bin Wang, Jian Wang, Wanchun Yang, Benzheng Wei, Jianzhong Chen
Förderung
- Demonstration Projects of Science and Technology for the People of Qingdao City
- National Nature Science Foundation of China
- Natural Science Foundation of Shandong Province
- Special fund of Qilu Health and Health Leading Talents Training Project
- Science and Technology of Traditional Chinese Medicine Project of Shandong Province
Zitieren
APA
Wang, B., Wang, J., Yang, W., Zhao, L., Wei, B., & Chen, J. (2024). Unveiling Allosteric Regulation and Binding Mechanism of BRD9 through Molecular Dynamics Simulations and Markov Modeling. Molecules. https://doi.org/10.3390/molecules29153496
Vancouver
Wang B, Wang J, Yang W, Zhao L, Wei B, Chen J. Unveiling Allosteric Regulation and Binding Mechanism of BRD9 through Molecular Dynamics Simulations and Markov Modeling. Molecules. 2024. doi:10.3390/molecules29153496
BibTeX
@article{Wang2024,
author = {Wang, Bin and Wang, Jian and Yang, Wanchun and Zhao, Lu and Wei, Benzheng and Chen, Jianzhong},
title = {Unveiling Allosteric Regulation and Binding Mechanism of BRD9 through Molecular Dynamics Simulations and Markov Modeling},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29153496}
}
EUVIMED